C12Y 207/11013
Protein kinase c
Official title: Protein kinase C (2.7.11.13)
C12Y207/11013 (Protein kinase c) appears on 73 US grants and 160 published applications in this corpus.
Search patents in C12Y- Granted patents
- 73
- Published applications
- 160
- Assignees
- 65
- Inventors
- 203
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 3 |
| 2003 | 2 | 6 |
| 2004 | 1 | 8 |
| 2005 | 1 | 40 |
| 2006 | 0 | 3 |
| 2007 | 0 | 7 |
| 2008 | 0 | 6 |
| 2009 | 1 | 12 |
| 2010 | 5 | 4 |
| 2011 | 6 | 3 |
| 2012 | 3 | 9 |
| 2013 | 3 | 3 |
| 2014 | 1 | 6 |
| 2015 | 6 | 3 |
| 2016 | 4 | 8 |
| 2017 | 4 | 5 |
| 2018 | 4 | 3 |
| 2019 | 2 | 3 |
| 2020 | 2 | 10 |
| 2021 | 3 | 4 |
| 2022 | 3 | 3 |
| 2023 | 3 | 2 |
| 2024 | 1 | 2 |
| 2025 | 0 | 5 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- G12-specific designer receptor exclusively activated by designer drugs28 Apr 2026US 12,612,442 B2Cell Networks GmbH
- Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis3 Feb 2026US 12,540,164 B2Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Immunotherapy methods and compositions involving tryptophan metabolic pathway modulators13 Feb 2024US 11,896,615 B2Juno Therapeutics, Inc.
- PKC-activating compounds for the treatment of neurodegenerative diseases21 Nov 2023US 11,820,745 B2Synaptogenix, Inc.
- Peptide kinase inhibitors and methods of use thereof12 Sep 2023US 11,753,453 B2
- Compositions and methods for treating or preventing t cell exhaustion28 May 2026US 2026/0146240 A1
- Multiple biomarker for cancer diagnosis and use thereof26 Feb 2026US 2026/0055469 A1Maxion Corp.
- Recombinant enhanced antiviral restrictors18 Dec 2025US 2025/0382596 A1The Regents of the University of California
- Bio-based production of succinic acid using vibrio natriegens25 Sep 2025US 2025/0297291 A1General Biological Corporation
- Preparation of novel triterpene alcohol derivatives with enhanced bioavailability for cancer, inflammation and pain treatment22 May 2025US 2025/0161327 A1Livful Inc.
Most cited
By later US patents
- Further use of protein kinase N beta46US 7,713,943 B2Silence Therapeutics GmbH · 2010
- Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof27US 5,681,747 AIsis Pharmaceuticals, Inc. · 1997
- Oligonucleotide modulation of protein kinase C22US 5,703,054 AIsis Pharmaceuticals, Inc. · 1997
- Antisense oligonucleotides against human protein kinase C22US 5,885,970 AIsis Pharmaceuticals, Inc. · 1999
- Modifications of peptide compositions to increase stability and delivery efficiency22US 8,067,532 B2KAI Pharmaceuticals, Inc. · 2011